Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! colspan="2" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
| colspan=" | | colspan="4" |'''Clinical manifestations''' | ||
! colspan="4" rowspan="2 | ! colspan="4" rowspan="2" |Para-clinical findings | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
|- | |- | ||
! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin Examination | |||
! colspan=" | |||
|- | |- | ||
! colspan="3 | ! colspan="3" |Lab Findings | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Type | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Color | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Risk factors | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin exam 3 | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dermoscopic Findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dermoscopic Findings | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Areas affected | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Areas affected | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Unique features | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Unique features | ||
Line 25: | Line 22: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''SCC in situ (Bowen's disease''') | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''SCC in situ (Bowen's disease''') | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Well-demarcated, scaly patch or plaque | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Erythematous | |||
* Skin colored | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Hyperkeratotic, or ulcerative lesions | * Hyperkeratotic, or ulcerative lesions | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Any cutaneous surface, including the head, neck, trunk, extremities, oral mucosa, shoulders, chest and back | * Any cutaneous surface, including the head, neck, trunk, extremities, oral mucosa, shoulders, chest and back | ||
Line 51: | Line 46: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Invasive squamous cell carcinoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Invasive squamous cell carcinoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Papules | ||
* Plaques | |||
* Nodules | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Poorly differentiated lesions are usually fleshy, soft, granulomatous papules or nodules that lack the hyperkeratosis that is often seen in well-differentiated lesions | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * none | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Poorly differentiated tumors may have ulceration, hemorrhage, or areas of necrosis. | * Poorly differentiated tumors may have ulceration, hemorrhage, or areas of necrosis. | ||
* Well-differentiated lesions usually appear as indurated or firm, hyperkeratotic | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * White circles, keratin, blood spots, and white structureless zones | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* same as above | * same as above | ||
Line 70: | Line 65: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Keratoacanthoma''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Keratoacanthoma''' | ||
| style="background: #F5F5F5; padding: 5px;" |Initial lesion: small pink macule | | style="background: #F5F5F5; padding: 5px;" |Initial lesion: small pink macule | ||
Later: papular quality and eventually forms a circumscribed nodule. | Later: papular quality and eventually forms a circumscribed nodule. | ||
| style="background: #F5F5F5; padding: 5px;" |The periphery of the nodule tends to be skin-colored or mildly erythematous and may have accompanying telangiectasias | | style="background: #F5F5F5; padding: 5px;" |The periphery of the nodule tends to be skin-colored or mildly erythematous and may have accompanying telangiectasias | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Skin color | * Skin color | ||
Line 86: | Line 77: | ||
* Chemical carcinogens (tar, pitch, polyaromatic hydrocarbons) | * Chemical carcinogens (tar, pitch, polyaromatic hydrocarbons) | ||
* Human papillomavirus infection | * Human papillomavirus infection | ||
| style="background: #F5F5F5; padding: 5px;" |The center of the nodule typically demonstrates a prominent keratinous core. | |||
| style="background: #F5F5F5; padding: 5px;" |White circles, keratin, blood spots, and white structureless zones | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Develops on sun-exposed areas of the skin. | * Develops on sun-exposed areas of the skin. | ||
Line 104: | Line 97: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Merkel cell carcinoma''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Merkel cell carcinoma''' | ||
| style="background: #F5F5F5; padding: 5px;" |rapidly growing, painless, firm, nontender, shiny, flesh-colored or bluish-red, intracutaneous nodule | | style="background: #F5F5F5; padding: 5px;" |rapidly growing, painless, firm, nontender, shiny, flesh-colored or bluish-red, intracutaneous nodule | ||
| style="background: #F5F5F5; padding: 5px;" |No more additional findings | | style="background: #F5F5F5; padding: 5px;" |No more additional findings | ||
| style="background: #F5F5F5; padding: 5px;" |Older patients with light skin tones | |||
| style="background: #F5F5F5; padding: 5px;" |No more additional findings | | style="background: #F5F5F5; padding: 5px;" |No more additional findings | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Milky red areas; linear, irregular vessels; and polymorphous vessels | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Starts on areas of skin exposed to the sun | * Starts on areas of skin exposed to the sun | ||
Line 122: | Line 113: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular basal cell carcinoma''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular basal cell carcinoma''' | ||
| style="background: #F5F5F5; padding: 5px;" |Pearly papule with telangiectasias | | style="background: #F5F5F5; padding: 5px;" |Pearly papule with telangiectasias | ||
| style="background: #F5F5F5; padding: 5px;" |Pink or flesh-colored papule | | style="background: #F5F5F5; padding: 5px;" |Pink or flesh-colored papule | ||
| style="background: #F5F5F5; padding: 5px;" |none | |||
| style="background: #F5F5F5; padding: 5px;" |No more additional findings | | style="background: #F5F5F5; padding: 5px;" |No more additional findings | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Typically presents on the face | | style="background: #F5F5F5; padding: 5px;" |Typically presents on the face | ||
| style="background: #F5F5F5; padding: 5px;" |May have a "rolled" border, where the periphery is more raised than the middle. | | style="background: #F5F5F5; padding: 5px;" |May have a "rolled" border, where the periphery is more raised than the middle. | ||
Line 135: | Line 124: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial basal cell carcinoma ''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Superficial basal cell carcinoma ''' | ||
| style="background: #F5F5F5; padding: 5px;" |Scaly patch | | style="background: #F5F5F5; padding: 5px;" |Scaly patch | ||
| style="background: #F5F5F5; padding: 5px;" |Erythematous lesion | | style="background: #F5F5F5; padding: 5px;" |Erythematous lesion | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" |No more additional findings | | style="background: #F5F5F5; padding: 5px;" |No more additional findings | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 150: | Line 137: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Prurigo nodules''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Prurigo nodules''' | ||
| style="background: #F5F5F5; padding: 5px;" |Firm, dome-shaped and itchy | | style="background: #F5F5F5; padding: 5px;" |Firm, dome-shaped and itchy | ||
| style="background: #F5F5F5; padding: 5px;" |ranging in size from a few millimeters to several centimeters and often symmetrically distributed | | style="background: #F5F5F5; padding: 5px;" |ranging in size from a few millimeters to several centimeters and often symmetrically distributed | ||
| style="background: #F5F5F5; padding: 5px;" |none | |||
| style="background: #F5F5F5; padding: 5px;" |Nodules can be flesh-colored, erythematous, or brown/black | | style="background: #F5F5F5; padding: 5px;" |Nodules can be flesh-colored, erythematous, or brown/black | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Extensor surfaces of the arms and legs and on the trunk | * Extensor surfaces of the arms and legs and on the trunk | ||
Line 173: | Line 158: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Common nevus''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Common nevus''' | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Dome-shaped, usually nonpigmented or hypopigmented nodules with a smooth surface | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Terminal hairs are often present | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 179: | Line 168: | ||
* Structureless skin-colored to light brown background pigmentation | * Structureless skin-colored to light brown background pigmentation | ||
* Residual brown globules (clods) or brown thick circles, mainly located around the hair follicles can sometimes be seen | * Residual brown globules (clods) or brown thick circles, mainly located around the hair follicles can sometimes be seen | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Blue nevus''' | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Bluish macules or papules | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 196: | Line 182: | ||
* Structureless blue pigmentation | * Structureless blue pigmentation | ||
* Structureless blue and white or blue and brown on some occasions | * Structureless blue and white or blue and brown on some occasions | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Head and neck, | * Head and neck, | ||
Line 211: | Line 192: | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Spitz nevus''' | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Spitz nevus''' | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nonpigmented Spitz nevus''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nonpigmented Spitz nevus''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |coiled vessels and a white network (also called reticular depigmentation or negative network) over a pink to reddish background | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 224: | Line 203: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Reed-like Spitz''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Reed-like Spitz''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |coiled vessels and a white network (also called reticular depigmentation or negative network) over a pink to reddish background | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 237: | Line 214: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Solar lentigo''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Solar lentigo''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 250: | Line 225: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lentigo Maligna''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lentigo Maligna''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 263: | Line 236: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lentigo Maligna Melanoma''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lentigo Maligna Melanoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 276: | Line 247: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sebaceous hyperplasia''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sebaceous hyperplasia''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 289: | Line 258: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lichen planus-like keratosis''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Lichen planus-like keratosis''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 302: | Line 269: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Seborrheic keratosis''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Seborrheic keratosis''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 315: | Line 280: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Actinic keratosis''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Actinic keratosis''' | ||
| style="background: #F5F5F5; padding: 5px;" |less pigmentation, and tend to be somewhat smaller in size. | | style="background: #F5F5F5; padding: 5px;" |less pigmentation, and tend to be somewhat smaller in size. | ||
| style="background: #F5F5F5; padding: 5px;" |Erythema | | style="background: #F5F5F5; padding: 5px;" |Erythema | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" |Hyperkeratosis | | style="background: #F5F5F5; padding: 5px;" |Hyperkeratosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 328: | Line 291: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular malignant melanoma''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nodular malignant melanoma''' | ||
| style="background: #F5F5F5; padding: 5px;" |Lump that has been rapidly growing over the past weeks | | style="background: #F5F5F5; padding: 5px;" |Lump that has been rapidly growing over the past weeks | ||
| style="background: #F5F5F5; padding: 5px;" |No more additional findings | | style="background: #F5F5F5; padding: 5px;" |No more additional findings | ||
| style="background: #F5F5F5; padding: 5px;" |none | |||
| style="background: #F5F5F5; padding: 5px;" |No more additional findings | | style="background: #F5F5F5; padding: 5px;" |No more additional findings | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 343: | Line 304: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Amelanotic melanoma''' | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Amelanotic melanoma''' | ||
| style="background: #F5F5F5; padding: 5px;" |Color usually pink, purple or normal skin color | | style="background: #F5F5F5; padding: 5px;" |Color usually pink, purple or normal skin color | ||
| style="background: #F5F5F5; padding: 5px;" |Usually have an asymmetrical shape with an irregular border | | style="background: #F5F5F5; padding: 5px;" |Usually have an asymmetrical shape with an irregular border | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" |Red, nonspecific lesion with slightly elevated borders | | style="background: #F5F5F5; padding: 5px;" |Red, nonspecific lesion with slightly elevated borders | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 00:47, 19 February 2019
Diseases | Clinical manifestations | Para-clinical findings | Additional findings | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Skin Examination | ||||||||||
Lab Findings | Histopathology | |||||||||
Type | Color | Risk factors | Skin exam 3 | Dermoscopic Findings | Areas affected | Unique features | ||||
Cutaneous squamous cell carcinoma | SCC in situ (Bowen's disease) |
|
|
|
|
|
|
|
| |
Invasive squamous cell carcinoma |
|
|
|
|
|
|
same as above | same as above | same as above | |
Keratoacanthoma | Initial lesion: small pink macule
Later: papular quality and eventually forms a circumscribed nodule. |
The periphery of the nodule tends to be skin-colored or mildly erythematous and may have accompanying telangiectasias |
|
The center of the nodule typically demonstrates a prominent keratinous core. | White circles, keratin, blood spots, and white structureless zones |
|
a history of rapid growth within weeks favors this diagnosis |
|
| |
Merkel cell carcinoma | rapidly growing, painless, firm, nontender, shiny, flesh-colored or bluish-red, intracutaneous nodule | No more additional findings | Older patients with light skin tones | No more additional findings | Milky red areas; linear, irregular vessels; and polymorphous vessels |
|
|
Blue-red, dome-shaped nodule | ||
Nodular basal cell carcinoma | Pearly papule with telangiectasias | Pink or flesh-colored papule | none | No more additional findings | Typically presents on the face | May have a "rolled" border, where the periphery is more raised than the middle. | Ulceration is frequent, and the term "rodent ulcer" refers to these ulcerated nodular BCCs | |||
Superficial basal cell carcinoma | Scaly patch | Erythematous lesion | No more additional findings |
|
||||||
Prurigo nodules | Firm, dome-shaped and itchy | ranging in size from a few millimeters to several centimeters and often symmetrically distributed | none | Nodules can be flesh-colored, erythematous, or brown/black |
|
Worsened by heat, sweating, or irritation from clothing |
|
Nodules range in number from few to hundreds
upper midback area is usually spared | ||
Common nevus |
|
|
|
|||||||
Blue nevus |
|
|
|
|||||||
Spitz nevus | Nonpigmented Spitz nevus | coiled vessels and a white network (also called reticular depigmentation or negative network) over a pink to reddish background | benign, indolent melanocyte proliferation that most commonly develops in children, adolescents, and young adults. | |||||||
Reed-like Spitz | coiled vessels and a white network (also called reticular depigmentation or negative network) over a pink to reddish background | benign, indolent melanocyte proliferation that most commonly develops in children, adolescents, and young adults. | ||||||||
Solar lentigo | ||||||||||
Lentigo Maligna | ||||||||||
Lentigo Maligna Melanoma | ||||||||||
Sebaceous hyperplasia | ||||||||||
Lichen planus-like keratosis | ||||||||||
Seborrheic keratosis | ||||||||||
Actinic keratosis | less pigmentation, and tend to be somewhat smaller in size. | Erythema | Hyperkeratosis | painful | ||||||
Nodular malignant melanoma | Lump that has been rapidly growing over the past weeks | No more additional findings | none | No more additional findings | Cells proliferate downwards through the skin (vertical growth) |
| ||||
Amelanotic melanoma | Color usually pink, purple or normal skin color | Usually have an asymmetrical shape with an irregular border | Red, nonspecific lesion with slightly elevated borders |
|
SCC in situ: Frequently, there is associated thickening of the epidermis (acanthosis), as well as hyperkeratosis and parakeratosis of the stratum corneum. In contrast to SCC in situ, actinic keratoses demonstrate only partial-thickness epidermal dysplasia.